Join
Live feed
·
PRReleasevia Quantisnow
Vivani Medical Inc. logo

Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management

ByQuantisnow·Wall Street's wire, on your screen.
VANI· Vivani Medical Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VANI (Vivani Medical Inc.) and more on Quantisnow.